Skip Navigation Links.
Collapse Knowledge BaseKnowledge Base
Expand Validation ApproachValidation Approach
Expand RegulationsRegulations
Expand Periodic AssessmentPeriodic Assessment
Expand Risk AnalysisRisk Analysis
Expand Facilities and HVAC SystemFacilities and HVAC System
Collapse Equipment ValidationEquipment Validation
Expand Analytical Instruments (AI)Analytical Instruments (AI)
Expand SterilizationSterilization
Expand Depyrogenation and EndotoxinsDepyrogenation and Endotoxins
Expand Utility SystemsUtility Systems
Expand Packaging and Shipping ValidationPackaging and Shipping Validation
Expand Cleaning Validation / Efficacy StudyCleaning Validation / Efficacy Study
Expand Computerized SystemsComputerized Systems
Expand Process ValidationProcess Validation

Shipping Validation Requirements - Guidelines

While CFR21 Section 211 sets quality standards, ICH, GDP, WHO, USP, and national authorities provide regulatory guidelines for maintaining quality during pharmaceutical transportation.

Key Regulatory References:

  1. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH):
    • ICH Q1A(R2): Stability Testing
    • ICH Q1D: Bracketing and Matrixing Designs
    • ICH Q1E: Evaluation for Stability Data
  2. Good Distribution Practice (GDP):
    • EU GDP Guidelines
    • U.S. FDA's Guidance - Distributing Publications
  3. World Health Organization (WHO):
    • WHO Good Distribution Practices
  4. U.S. Pharmacopeia (USP):
    • USP Chapter <1079>: Good Storage and Shipping Practices
  5. National Regulatory Authorities:
    • Each country may have its own regulatory requirements and guidelines related to the distribution and transportation of pharmaceutical products. Pharmaceutical companies are typically required to comply with the regulations of the countries in which their products are distributed.